Virtus ETF Advisers LLC Curis Inc Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $24,742 - $84,680	-34,848 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $4,765 - $10,583	-2,063 Reduced 5.59%	34,848 $83,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $47,045 - $85,527	10,572 Added 40.14%	36,911 $176,000
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $9,570 - $12,204	-1,379 Reduced 4.98%	26,339 $206,000
Q2 2021 Aug 10, 2021	BUY	$7.45 - $16.27 $206,499 - $450,971	27,718 New	27,718 $224,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $291M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.